Medical Toxicology

News

The latest in medical toxicology

Stay informed with the latest in medical toxicology. Explore news on research, poisoning outbreaks, global trends, and new treatments. Our news section covers everything from environmental toxins to regulatory updates, keeping you ahead in this field.

Public Health Warnings and Recalls

FDA Finds Dangerously High Yohimbine Plus Hidden Tadalafil and Flibanserin in WAP Sensual Enhancement

02 Sept 2026 · Updated 01 Oct 2026

WAP Sensual Enhancement under laboratory review beside labeled evidence samples for dangerously high yohimbine, undeclared tadalafil, and undeclared flibanserin.

Public Health Warnings and Recalls

FDA Glutathione Endotoxin Investigation Expands With Greenwich Rx Recall

02 Sept 2026 · Updated 04 Oct 2026

Greenwich Rx glutathione 200 mg/mL recall highlights 10 affected lots, potential elevated endotoxin, and two ED reports after IV administration.

Public Health Warnings and Recalls

FDA Finds Hidden Sildenafil and Tadalafil in Two Sexual-Enhancement Products

16 Aug 2026 · Updated 01 Oct 2026

Two unbranded sexual-enhancement products beside sildenafil and tadalafil tablets, with a nitrate medication warning and blood-pressure monitor.

Public Health Warnings and Recalls

FDA Confirms Yimmugo C795314 Withdrawal After Safety Alert

16 Aug 2026 · Updated 16 Oct 2026

Hospital pharmacy graphic shows Yimmugo lot C795314 voluntarily withdrawn October 7 after an FDA safety alert, alongside four August withdrawn lots.

Public Health Warnings and Recalls

FDA Expands Yellow Oleander Weight-Loss Product Alert

16 Aug 2026 · Updated 16 Oct 2026

FDA yellow oleander alert graphic showing three September product additions, with Niwali capsules and pieces recalled and Easy Forte under recall recommendation.

Public Health Warnings and Recalls

California Amatoxin Outbreak: 50 Poisonings, Four Deaths Reported

27 Jul 2026 · Updated 01 Oct 2026

Death Cap and Western Destroying Angel mushrooms beside a California outbreak map and liver-injury illustration representing amatoxin poisoning.

Public Health Warnings and Recalls

FDA Calls for Stronger Infant Formula Safeguards After Botulism Outbreaks

15 Jul 2026 · Updated 02 Oct 2026

Nara and ByHeart infant-formula samples linked by whole-genome sequencing and shared supply-chain evidence while the exact contamination source remains unresolved.

Public Health Warnings and Recalls

Weekly Safety Pulse: FAERS & Recalls

21 Jan 2026 · Updated 30 Sept 2026

FDA safety updates infographic highlighting preventable medication risks including wrong-drug administration with Septocaine and mepivacaine, IGIV and IGSC lot-specific anaphylaxis alerts for Asceniv and Bivigam, GLP-1 receptor agonist labeling update removing suicidal ideation language, opioid long-term overdose risk warnings, potassium chloride mislabeling recall, adulterated supplements, and counterfeit Ozempic warnings in the U.S. drug supply.

Public Health Warnings and Recalls

FDA Safety Alert: Nicotine Pouches and Pediatric Poisoning Risk

15 Jan 2026 · Updated 28 Sept 2026

FDA warning infographic showing rising nicotine pouch ingestions in children under 5, highlighting common poisoning symptoms, emergency evaluation tips, and child-resistant packaging and poison-prevention steps for families

Public Health Warnings and Recalls

FDA Issues Critical Age Limits for Scopolamine Patch Safety

15 Jan 2026 · Updated 02 Oct 2026

FDA safety alert image showing a scopolamine transdermal patch held by gloved hands with a medical device in the background, illustrating new FDA age limits and pediatric safety concerns for scopolamine patch use
Showing 11–20 of 24
123